Thrombotic Thrombocytopenic Purpura Therapy
Research from Alfa Institute of Biomedical Sciences yields new data on thrombotic thrombocytopenic purpura therapy
Published in TB and Outbreaks Week, February 13th, 2007
New research, "Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection," is the subject of a report. According to a study from Athens, Greece, "Escherichia coli O157:H7 is a foodborne pathogen causing haemorrhagic colitis, which is sometimes complicated by haemolytic uraemic syndrome or thrombotic thrombocytopenic purpura. To review the available evidence regarding the question of whether antibiotics are effective or harmful for the treatment of patients infected with E. coli O157:H7 infection."
"We searched in the PubMed for relevant laboratory and clinical studies published...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Influenza Virus
Scientists assess the risk of a potential flu pandemic spread via global airlines - HIV/AIDS Co-Infection Screening
Data from University of California, Division of HIV provide new insights into HIV/AIDS co-infection screening - HIV/AIDS Co-Infection Therapy
Research in the area of HIV/AIDS co-infection therapy reported from Institute of Infectious Disease and Molecular Medicine - HIV/AIDS Co-Infection Therapy
Research on HIV/AIDS co-infection therapy detailed by scientists at National Institute of Allergy and Infectious Disease - Tuberculosis
Data on tuberculosis described by researchers at University of Pavia - Tuberculosis
Data on tuberculosis detailed by researchers at University of Central Florida, Burnett College of Biomedical Sciences - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
